Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Hospices Civils De Lyon
Sponsor

Hospices Civils De Lyon

France 3 Quai Des Celestins, Bp 2251, 69229 Lyon, France

About the sponsor

Clinical research covers advanced and metastatic solid tumours, with particular attention to mesothelioma, gastric adenocarcinoma, ovarian cancer, neuroendocrine carcinoma, thymic malignancies, anaplastic thyroid carcinoma, and gestational trophoblastic neoplasia. The portfolio also includes studies in metastatic prostate cancer and other treatment-resistant cancers.

  • Malignant pleural and peritoneal mesothelioma
  • Advanced gastric cancer
  • Rare thoracic and endocrine tumours
  • Gastro-enteropancreatic neuroendocrine neoplasms

Research interest extends to immunotherapy, targeted cancer treatment, and surgical or locoregional management in advanced disease.

About Specializations

Hospices Civils De Lyon runs clinical trials in conditions such as Parkinson's disease, Peritoneal mesothelioma malignant, Epilepsy, Severe myoclonic epilepsy of infancy, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

37 clinical trials

Parkinson's disease

Recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:1-[[(3S)-2,3-DIHYDRO-1,4-BENZODIOXIN-3-YL]METHYL]-4-[3-((11C)METHOXYMETHYL)-2-PYRIDINYL]PIPERAZINE
  • Sponsor:Hospices Civils De Lyon

Severe myoclonic epilepsy of infancy

Recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · Healthy volunteers
  • Substances:4-Fluoro-N-[2-[4-(2-Methoxyphenyl)Piperazin-1-Yl]Ethyl]-N-Pyridin-2-Ylbenzamide
  • Sponsor:Hospices Civils De Lyon

Prostate cancer metastatic

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Gozetotide
  • Sponsor:Hospices Civils De Lyon

Toxic epidermal necrolysis+1

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Filgrastim
  • Sponsor:Hospices Civils De Lyon

Renal failure

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Hospices Civils De Lyon

Haemodialysis

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Hospices Civils De Lyon

Drug dependence

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Baclofen
  • Sponsor:Hospices Civils De Lyon

Anti-neutrophil cytoplasmic antibody positive vasculitis

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Hospices Civils De Lyon

Systemic lupus erythematosus

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Abacavir
  • Sponsor:Hospices Civils De Lyon

Obesity

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Colecalciferol
  • Sponsor:Hospices Civils De Lyon

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

ClinicalTrials.eu

Every clinical trial in Europe, in plain language.

Explore the full ecosystem of clinical research in Europe.

Search trials

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).